Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression.

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Abstract Text:

Resistin is a member of adipokine family involved in the regulation of inflammatory reactions and insulin sensitivity. In presented study its possible role in the development of benign prostate hyperplasia and prostate cancer was evaluated. Blood samples and prostate specimens were collected from 26 patients with benign prostate hyperplasia (BPH) and from 42 patients with prostate cancer (PCa) stage pT2 (n=18) and pT3 (n=24). Selected metabolic and biochemical parameters and serum resistin levels were measured and anthropometric measurements were performed as well as tissue immunohistochemistry for resistin. Serum resistin levels did not differ significantly between benign hyperplasia and prostate cancer but in cancer patients there was a trend towards decrease with higher cancer stage. Moreover, serum resistin levels were significantly lower in patients with seminal vesicle invasion in comparison to those without invasion. While in BPH serum resistin levels correlated with insulin resistance, inflammatory status and cortisol, in PCa positive correlation with F/T PSA ratio and cortisol was observed. Tissue immunohistochemistry did not show any differences in staining pattern between benign and neoplastic prostate tissue. We conclude that serum resistin levels do not significantly differ between patients with benign prostate hyperplasia and prostate cancer, but there is a trend towards decrease in resistin serum levels in advanced cancer cases. Key words: Immunohistochemistry, inflammation, insulin resistance, prostate cancer, resistin.

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neoplasma

VOLUME: 55

Page Numbers: 442-6

Journal Abbreviation: Neoplasma

ISSN: 0028-2685

DAY: 30

MONTH: 07

YEAR: 2008

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 377266

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression.

AFFILIATION:

Country: Slovakia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neoplasma

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression Related Publications

• "An international journal ...".
• Effect of Environment on the Growth and Glycosides of Callus Tissue of Digitalis lanata.
• Effect of Nutrients Deficiency on Organic Constituents in Digitalis lanata.
• Fatigue in a College Athlete- Football: 1154: June 2 10:20 AM - 10:40 AM.
• Gone green.
• Hyperthermia-induced reorganization of microtubules and microfilaments and cell killing in CHO AA8 cell line.
• Incidence of skeletal deformities in endemic fluorosis.
• Mimotopes and proteome analyses using human genomic and cDNA epitope phage display.
• Number of valves in superficial veins of the leg.
• Prediction of selected skinfold measurements from anthropometric and performance variables: 2038: board #108 may 31 2:00 PM 3:30 PM.
• Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: Possible role in cancer progression.
• The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma - results of pilot study.
• The timing and sequence of appearance of the distal branches of the human embryonic vestibular ganglion.
• Variability of posterior veins of the left ventricle in the adult human heart.
• [Not Available.]
• [Not Available.]